CLONAZEPAM - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN EPILEPSY

被引：112

作者：

PINDER, RM ^{[1
]}

BROGDEN, RN ^{[1
]}

SPEIGHT, TM ^{[1
]}

AVERY, GS ^{[1
]}

机构：

[1] AUSTRALASIAN DRUG INFORMATION SERV, Auckland 10, NEW ZEALAND

来源：

DRUGS | 1976年 / 12卷 / 05期

关键词：

SUBCORTICAL EPILEPTOGENIC TISSUES; BENZODIAZEPINE RO 5-4023; CLINICAL-EXPERIENCE; STATUS EPILEPTICUS; ANTICONVULSANT PROPERTIES; ANTIEPILEPTIC PROPERTIES; RO-5-4023; CLONAZEPAM; INFANTILE SPASMS; 5-HT METABOLISM; TONIC STATUS;

D O I：

10.2165/00003495-197612050-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：321 / 361

页数：41

共 124 条

[1]

AARLI JA, 1973, ACTA NEUROL SCAND, V49, P11

[2]

Balassa M, 1972, Wien Med Wochenschr, V122, P27

[3]

BANG FB, IN PRESS

[4]

BANZIGER R, 1967, ARCH INT PHARMACOD T, V167, P245

[5]

BARNETT AM, 1973, S AFR MED J, V47, P1683

[6]

BEAUSSART M, 1973, SEMAINE HOPITAUX P S, V49, P39

[7]

Beck H, 1973, TRAITEMENT ETATS MAL, V49

[8]

Bergamini L., 1970, EEG EMG, V1, P182

[9]

BERGAMINI L, 1972, RIVOTRIL S MARSEILLE

[10] PHARMACOKINETICS OF ANTICONVULSANT DRUG CLONAZEPAM EVALUATED FROM SINGLE ORAL AND INTRAVENOUS DOSES AND BY REPEATED ORAL-ADMINISTRATION [J].

BERLIN, A ;

DAHLSTROM, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :155-159

← 1 2 3 4 5 6 7 8 9 10 →